Keratosis follicularis spinulosa decalvans

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2340OMIM:308800Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Keratosis follicularis spinulosa decalvans (KFSD), also known as Siemens syndrome or keratosis pilaris decalvans, is a rare inherited skin disorder belonging to the group of keratosis pilaris atrophicans conditions. It primarily affects the hair follicles, leading to widespread follicular hyperkeratosis (rough, spiny bumps around hair follicles), progressive scarring alopecia (permanent hair loss) of the scalp, and loss of eyebrows and eyelashes. The condition typically begins in infancy or early childhood with keratosis pilaris-like lesions on the face and body, followed by progressive cicatricial alopecia of the scalp that worsens over time. KFSD predominantly affects the skin, hair, and eyes. Ocular involvement is common and may include photophobia (light sensitivity), blepharitis, and corneal dystrophy. The follicular keratotic papules can be widespread, affecting the face, neck, trunk, and extremities. Males tend to be more severely affected than females, consistent with the X-linked inheritance pattern. The condition is caused by mutations in the MBTPS2 gene (also known as SAT-1), located on the X chromosome, which encodes a membrane-bound transcription factor protease involved in cholesterol and fatty acid metabolism. There is currently no cure for KFSD. Treatment is symptomatic and supportive. Topical keratolytics (such as urea-based creams or salicylic acid) and emollients may help manage the follicular hyperkeratosis. Topical or oral retinoids have been used with variable success to reduce keratotic lesions, though they do not prevent progressive hair loss. Anti-inflammatory treatments may help manage scalp inflammation. Ophthalmologic monitoring is recommended for patients with eye involvement. Early dermatologic and genetic counseling is advised for affected families.

Clinical phenotype terms— hover any for plain English:

Facial erythemaHP:0001041Progressive alopeciaHP:0002287Scarring alopecia of scalpHP:0004552Follicular hyperkeratosisHP:0007502FolliculitisHP:0025084Keratosis pilarisHP:0032152Hyperkeratotic papuleHP:0045059BlepharitisHP:0000498
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Keratosis follicularis spinulosa decalvans.

View clinical trials →

No actively recruiting trials found for Keratosis follicularis spinulosa decalvans at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Keratosis follicularis spinulosa decalvans community →

No specialists are currently listed for Keratosis follicularis spinulosa decalvans.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Keratosis follicularis spinulosa decalvans.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Keratosis follicularis spinulosa decalvansForum →

No community posts yet. Be the first to share your experience with Keratosis follicularis spinulosa decalvans.

Start the conversation →

Latest news about Keratosis follicularis spinulosa decalvans

No recent news articles for Keratosis follicularis spinulosa decalvans.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Keratosis follicularis spinulosa decalvans

What is Keratosis follicularis spinulosa decalvans?

Keratosis follicularis spinulosa decalvans (KFSD), also known as Siemens syndrome or keratosis pilaris decalvans, is a rare inherited skin disorder belonging to the group of keratosis pilaris atrophicans conditions. It primarily affects the hair follicles, leading to widespread follicular hyperkeratosis (rough, spiny bumps around hair follicles), progressive scarring alopecia (permanent hair loss) of the scalp, and loss of eyebrows and eyelashes. The condition typically begins in infancy or early childhood with keratosis pilaris-like lesions on the face and body, followed by progressive cicatr

How is Keratosis follicularis spinulosa decalvans inherited?

Keratosis follicularis spinulosa decalvans follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Keratosis follicularis spinulosa decalvans typically begin?

Typical onset of Keratosis follicularis spinulosa decalvans is infantile. Age of onset can vary across affected individuals.